DIR | NACDS

NACDS Brings to Oklahoma Its Focus on PBM Reform Law Enforcement NACDS’ Principles of PBM Reform include “stopping the undercutting of reform laws” – as part of a comprehensive effort to end “pharmaceutical benefit manipulation” that harms patients, employers, taxpayers, communities, and pharmacies

admin2023-04-25T11:16:57-04:00Categories: Press Release|Tags: DIR, PBM, Pharmacy_Value, Reimbursement, States|

NACDS’ Principles of PBM Reform include “stopping the undercutting of reform laws” – as part of a comprehensive effort to end “pharmaceutical benefit manipulation” that harms patients, employers, taxpayers, communities, and pharmacies.

NACDS Praises Sens. Wyden, Crapo for Continued Bipartisan Push to Reform “Pharmaceutical Benefit Manipulation” As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation

admin2023-04-20T09:59:23-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Reimbursement|

As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation.

NACDS Urges Transparency, Accountability, and Fair Competition as Senate Finance Explores PBMs’ Impact on Healthcare Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue

admin2023-03-30T10:11:58-04:00Categories: Press Release|Tags: Congress, DIR, PBM, Pharmacy Value, Reimbursement|

Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.

In Case You Missed It: HHS Secretary Xavier Becerra Talks ‘Clever’ PBM Middlemen Tactics During Senate Hearing

admin2023-03-29T17:38:36-04:00Categories: In Case You Missed It|Tags: Congress, DIR, PBM, Reimbursement|

Last week, Health and Human Services (HHS) Secretary Xavier Becerra appeared before the U.S. Senate Appropriations Committee to provide testimony on the FY 2024 Funding Request and Budget Justification of the Department of Health and Human Services.

NACDS Praises Continued Focus and Diligence on PBM Reform as Senate Commerce Committee Advances Bill

admin2023-03-22T15:02:07-04:00Categories: Press Release|Tags: Congress, DIR, Reimbursement|

NACDS President and Chief Executive Officer Steven C. Anderson issued the following statement today upon passage of the Pharmacy Benefit Manager Transparency Act (S. 127) by the U.S. Senate Commerce, Science, and Transportation Committee:

NACDS Urges PBM Reform, Medicare Pharmacy Services, and PREP Act Extension as Senate Committee Explores Healthcare Workforce Topics Announces updated national, state, and Congressional District polling relevant to priority issues

admin2023-03-21T15:36:51-04:00Categories: Press Release|Tags: Congress, DIR, Medicare, Preparedness, Reimbursement, Vaccinations|

Announces updated national, state, and Congressional District polling relevant to priority issues.

NACDS Statement in Response to Introduction of PBM Reform Legislation in Florida

admin2023-03-06T16:55:57-05:00Categories: Press Release|Tags: DIR, PBM, Reimbursement, States|

NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:

NACDS D.C. Fly-In Event Centers on Future of Patient Access Pharmacy benefit manager (PBM) reform; comprehensive direct and indirect remuneration (DIR) fee reform; and sustaining patient access to vaccinations, testing, and treatment among key topics at the February 28-March 1 program

admin2023-03-03T12:29:04-05:00Categories: Press Release|Tags: Congress, DIR, Preparedness, Reimbursement, RxIMPACT, Vaccinations|

Pharmacy benefit manager (PBM) reform; comprehensive direct and indirect remuneration (DIR) fee reform; and sustaining patient access to vaccinations, testing, and treatment among key topics at the February 28-March 1 program.